Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial
Nordanstig J, Arslan EG, Catarig AM, et al.
Eur Heart J. Pub. online 5 Mar 2026.
Leggi
Breaking news
Everyone or just some? cost-effectiveness of general population versus targeted screening strategies for type 1 diabetes in Canada
Mital S, Schatz DA, Haller MJ, et al.
Diabetes Care. Pub. online 2 Mar 2026.
Leggi
Small extracellular vesicle external surface adiponectin-mediated adipocytes/cardiomyocytes communication in diabetic ischemic heart failure
Zhang Z, Zhu D, Liu C, et al.
Circulation. Pub. online 2 Mar 2026.
Leggi
Joint TOS/OMA/OAC expert guidance statement on the pharmacological management of United States adults with overweight or obesity using the GRADE approach
Alexander L, Purnell JQ, Burridge K, et al.
Obesity (Silver Spring). Pub. online 5 Mar 2026.
Leggi
Finerenone in type 1 diabetes and chronic kidney disease
Heerspink HJL, Birkenfeld AL, Cherney DZI, et al.
N Engl J Med. Pub. online 5 Mar 2026.
Leggi
Obesity and metabolic syndrome predict polyneuropathy over 5 years in recent-onset type 2 diabetes and normal glucose tolerance
Sipola G, Strom A, Wagner R, et al.
Diabetes Metab Res Rev. Pub. online 3 Mar 2026.
Leggi
Additive cardiorenal benefits of finerenone and SGLT2 inhibitor combination therapy in diabetic CKD: a propensity-matched real-world study
Mortada I, Lee A, Sahu A, et al.
Am J Cardiol. Pub. online 27 Feb 2026.
Leggi
A novel chronotype-based mediterranean diet pyramid: an updated representation by the Italian Society of Endocrinology (SIE) and the Italian Society of Dietetics and Clinical Nutrition (ADI)
Barrea L, Verde L, Camajani E, et al.
Curr Nutr Rep. 2026;15(1):10.
Leggi
Impact of early and tight HbA1c control on the risk of long-term complications and cardiovascular death in patients with type 2 diabetes from the Swedish National Diabetes Register
Mount J, Boye K, Lebrec J, Wilkes E, et al.
Diabetes Obes Metab. Pub. online 27 Feb 2026.
Leggi